SECTION I · THE BRIEF
Brief #01180Updated 17 JUN 2026QUINCY, MAGreenhouseSOFTWARE COMPANIES
Employbl Company Profile

Manager, Antibody Characterization

Twist Bioscience is a public company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai,…

Location
Quincy, MA
Company size
923–923
Posted
3w ago
Via
Greenhouse
Section II · Premium ProfileMembers only
  • 01Comp band & equity packageLocked
  • 02Seniority & experience requirementsLocked
  • 03Interview process & rubricLocked
  • 04Hiring manager & team contextLocked
  • 05Growth trajectory in this roleLocked
  • 06Offer & decision timelineLocked

7-day free trial · $25/mo · cancel anytime

Twist Bioscience logo

Manager, Antibody Characterization - Twist Bioscience

View Company Profile
Job Title
Manager, Antibody Characterization
Job Location
USA - Quincy, MA
Job Description

Manager, Antibody Characterization (onsite in Quincy, MA)

JOB DESCRIPTION 

This is a management position that provides support for bioanalytical characterization for a variety of therapeutic antibody candidates. This role oversees our Antibody Characterization team and is responsible for managing, optimizing, and troubleshooting a range of workflows, including immunoassays, affinity analysis, functional assays, and target binding characterization.

ESSENTIAL FUNCTIONS

  • Lead, manage, and develop a team of scientists and research associates in our Antibody Characterization department.
  • Provide technical guidance (assay development, analysis, and data reporting) in a range of areas, including high-throughput ELISA, flow cytometry, kinetic assays (BLI and SPR), advanced/custom characterization, and functional screening.
  • Serve as an end-to-end technical lead for a variety of in vivo antibody discovery programs and contract services, contributing to scientific planning and feasibility review during project scoping.
  • Review, critically analyze, and present data to customers to facilitate antibody lead selection for a variety of concurrent antibody discovery programs.
  • Work closely with the Project Management team to communicate timelines and deliverables to internal and external stakeholders and customers.
  • Work closely with all scientific departments and senior management to ensure excellent management of all activities and effective communication.
  • Promote operational and scientific excellence by driving continuous process improvement.
  • Stay up to date with recent developments in antibody discovery methods and technologies, and help guide the advancement of our laboratory capabilities in alignment with strategic company goals.
  • Spend approximately 30-50% of your time performing wet-lab benchwork alongside the team.

POSITION QUALIFICATIONS

  • PhD in a related technical field with 3+ years of management experience in biopharmaceutical analytical development, or MS with 5+ years of experience, including 3+ years of management experience.
  • Expert knowledge of biologics characterization assays: extensive hands-on experience required in ELISA, flow cytometry, and/ or SPR/BLI with Carterra and Sartorius Octet.
  • Very strong track record of developing, executing, and analyzing common assay formats for biologics discovery, such as high-throughput screening, epitope binning, ligand blocking analysis, affinity analysis, and cell-based functional assays.
  • Able to independently manage and prioritize tasks in a fast-paced environment that hinges on overlapping projects and sensitive workflow timelines.
  • Advanced understanding of in vivo antibody discovery concepts.
  • Proven ability to assess, interpret, and present complex scientific data effectively and with a high level of integrity and ethics.
  • Proven management skills for both projects and people, with a strong track record of building trust and developing teams at a variety of levels.
  • Exceptional written and verbal communication skills, including customer-facing communication.
  • Highly organized and detail-oriented with a focused, problem-solving mentality to address projects and logistics.

About Twist Bioscience

Twist Bioscience synthesizes genes from scratch, known as “writing” DNA. Just as children learn to both read and write, the next phase of development for the genomics revolution is the ability to write DNA.

At Twist Bioscience, we work in service of people who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals and data storage, our unique silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers.

Twist Bioscience Corporation is an Equal Opportunity Employer. Twist Bioscience Corporation provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, genetic characteristics, or any other category protected by law.

The base cash compensation for this Massachusetts-based role is below. In addition to base salary, this role is eligible for bonus, equity, and a generous benefits package. Final compensation amounts are determined by multiple factors, including candidate skill, experience, expertise, and location and may vary from the amount listed above. Compensation may be different in other locations.

Massachusetts Pay Range
$111,879$146,200 USD

Get the Saturday tech briefing

New company profiles, funding moves, and who’s hiring across the market — every Saturday morning.

Where this role is based

Quincy, MA

Loading map…

Twist Bioscience Headquarters Location

San Francisco, CA

View company profile

Twist Bioscience Company Size

Between 923 - 923 employees

Twist Bioscience Founded Year

2013

Twist Bioscience Total Amount Raised

$553,110,720

Twist Bioscience Funding Rounds

View funding details
  • Post Ipo Equity

    $250M

  • Post Ipo Equity

    $250M

  • Post Ipo Equity

    $50M

  • Post Ipo Equity

    $50M

  • Series Unknown

    $50M

  • Series Unknown

    $50M

  • IPO

    Unknown

  • Series Unknown

    $27M

  • Series Unknown

    $27M

  • Series Unknown

    $33M

  • Series Unknown

    $33M

  • Series D

    $61M

  • Series D

    $61M

  • Series C

    $37M

  • Series C

    $37M

  • Debt Financing

    $10M

  • Debt Financing

    $10M

  • Series B

    $26M

  • Series B

    $26M

  • Series A

    $9.1M

  • Series A

    $9.1M